Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 3311126 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | negation | |
| this policy of not using family members, particularly the hla-matched bone marrow donor, to provide blood products prior to transplantation has been extended to leukaemia as well. | |||||||
| 3312304 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| the hla system is the major histocompatibility system of man and was found through a search for blood group-like determinants on white blood cells that would be effective in matching for transplantation. | |||||||
| 3312304 | HLA (HLA) | diseases | NA | NA | NA | unclassified | |
| polymorphism in the hla region is thus associated with a wide variety of diseases with an immune aetiology. | |||||||
| 3312835 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| our data suggest that marrow transplantation is possible for jcml patients without hla-identical donors, but for successful marrow transplantation different measures are necessary to eradicate the abnormal stem cell compartment. | |||||||
| 3313839 | HLA-B (HLA-B) | transplantation | NA | NA | NA | unclassified | |
| the analysis indicated that factors influencing a patient's innate nonspecific immune response (e.g., dt and ptr) are important determinants of graft survival and should be taken into account when considering matching for specific hla-b or dr antigens prior to transplantation. | |||||||
| 3313839 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | unclassified | |
| the analysis indicated that factors influencing a patient's innate nonspecific immune response (e.g., dt and ptr) are important determinants of graft survival and should be taken into account when considering matching for specific hla-b or dr antigens prior to transplantation. | |||||||
| 3313839 | HLA (HLA) | cadaver | NA | NA | NA | unclassified | |
| from a study population of 208 consecutive first cadaver renal transplant recipients a proportional hazard model was used to simultaneously quantify the role in graft failure of matching for specific hla antigens and constitutional factors (age, sex, duration of dialysis (dt), and pre- (ptr) and peri-(pertr) operative transfusions) that influence nonspecific immune response. | |||||||
| 3318032 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| these results may be relevant for the transplantation of hla-incompatible marrow in man, particularly after in vivo t cell depletion, where graft failure is frequent. | |||||||
| 3321413 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| 99 patients with hematological malignancies underwent allogeneic marrow transplantation from hla-identical sibling donors and were randomized to receive one of two forms of infection prophylaxis while granulocytopenic: (1) prophylactic systemic antibiotics in a conventional hospital room (psa, 50 patients) or (2) decontamination, isolation in a laminar air flow room and the administration of prophylactic systemic antibiotics (laf + psa, 49 patients). | |||||||
| 3321413 | HLA IDENTICAL (HLA-IDENTICAL) | infection | NA | NA | NA | unclassified | |
| 99 patients with hematological malignancies underwent allogeneic marrow transplantation from hla-identical sibling donors and were randomized to receive one of two forms of infection prophylaxis while granulocytopenic: (1) prophylactic systemic antibiotics in a conventional hospital room (psa, 50 patients) or (2) decontamination, isolation in a laminar air flow room and the administration of prophylactic systemic antibiotics (laf + psa, 49 patients). | |||||||
Copyright 2024